Float Short %

4.49

Margin Of Safety %

Put/Call OI Ratio

0.46

EPS Next Q Diff

0.96

EPS Last/This Y

3.54

EPS This/Next Y

6.21

Price

171.99

Target Price

229.34

Analyst Recom

Performance Q

9.04

Relative Volume

0.46

Beta

0.37

Ticker: ASND

19 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	ASND	175.53	0.70	0.97	7429
2025-06-03	ASND	174.36	0.68	1.49	6936
2025-06-04	ASND	173.67	0.64	0.51	6894
2025-06-05	ASND	177.43	0.64	32.00	6818
2025-06-06	ASND	173.28	0.65	999.99	6841
2025-06-09	ASND	173.27	0.65	0.45	6842
2025-06-10	ASND	172.34	0.66	0.00	6824
2025-06-11	ASND	171.84	0.66	0.00	6825
2025-06-12	ASND	170.91	0.66	1.67	6832
2025-06-13	ASND	170.68	0.66	1.72	6838
2025-06-16	ASND	177.74	0.66	2.66	6825
2025-06-17	ASND	173.17	0.67	16.59	6890
2025-06-18	ASND	170.48	0.73	0.00	7154
2025-06-20	ASND	176.65	0.73	0.80	7161
2025-06-23	ASND	175.65	0.46	0.08	3978
2025-06-24	ASND	178.88	0.46	1.43	3994
2025-06-25	ASND	173.32	0.46	0.14	4024
2025-06-26	ASND	172.95	0.46	0.00	4037
2025-06-27	ASND	171.92	0.46	0.40	4037
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	ASND	175.70	25.1	30.9	-4.24
2025-06-03	ASND	174.40	25.1	55.3	-4.24
2025-06-04	ASND	173.86	25.1	53.0	-4.24
2025-06-05	ASND	177.55	25.1	45.6	-4.25
2025-06-06	ASND	173.15	25.1	58.7	-4.25
2025-06-09	ASND	173.15	25.1	51.4	-4.25
2025-06-10	ASND	172.34	25.1	52.8	-4.14
2025-06-11	ASND	171.62	25.1	52.4	-4.14
2025-06-12	ASND	170.92	25.1	52.4	-4.14
2025-06-13	ASND	170.73	25.1	51.0	-4.14
2025-06-16	ASND	177.81	27.2	38.6	-3.87
2025-06-17	ASND	172.90	27.2	57.6	-3.87
2025-06-18	ASND	170.71	27.2	52.7	-3.87
2025-06-20	ASND	176.90	27.2	38.5	-3.87
2025-06-23	ASND	175.72	27.2	49.8	-3.87
2025-06-24	ASND	179.34	27.2	42.2	-3.87
2025-06-25	ASND	173.05	27.2	57.4	-3.87
2025-06-26	ASND	172.88	27.2	47.7	-3.87
2025-06-27	ASND	171.99	27.2	48.9	-3.87
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	ASND	0.00	-3.10	6.27
2025-06-03	ASND	0.00	-3.10	6.27
2025-06-04	ASND	0.00	-3.10	6.27
2025-06-05	ASND	0.00	-3.10	6.27
2025-06-06	ASND	0.00	-3.10	6.27
2025-06-09	ASND	0.00	-3.12	6.27
2025-06-10	ASND	0.00	-3.12	6.27
2025-06-11	ASND	0.00	-3.12	5.63
2025-06-12	ASND	0.00	-3.12	5.63
2025-06-13	ASND	0.00	-3.12	5.63
2025-06-16	ASND	0.00	1.95	5.63
2025-06-17	ASND	0.00	1.95	5.63
2025-06-18	ASND	0.00	1.95	5.63
2025-06-20	ASND	0.00	1.95	5.63
2025-06-23	ASND	0.00	1.74	5.63
2025-06-24	ASND	0.00	1.74	5.63
2025-06-25	ASND	0.00	1.74	5.63
2025-06-26	ASND	0.00	1.74	4.49
2025-06-27	ASND	0.00	1.74	4.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.66

Avg. EPS Est. Current Quarter

-1.39

Avg. EPS Est. Next Quarter

-0.7

Insider Transactions

Institutional Transactions

1.74

Beta

0.37

Average Sales Estimate Current Quarter

136

Average Sales Estimate Next Quarter

176

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

6.5

Max Drawdown 5-Year %

-61.7

Target Price

229.34

P/E

Forward P/E

80.97

PEG

P/S

26.38

P/B

P/Free Cash Flow

EPS

-6.29

Average EPS Est. Cur. Y

-3.87

EPS Next Y. (Est.)

2.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-93.22

Relative Volume

0.46

Return on Equity vs Sector %

156.1

Return on Equity vs Industry %

174

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

48.9

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y